2-241096116-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_182501.4(MTERF4):c.1028A>T(p.Glu343Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000166 in 1,611,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_182501.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTERF4 | NM_182501.4 | c.1028A>T | p.Glu343Val | missense_variant | 4/4 | ENST00000391980.7 | NP_872307.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTERF4 | ENST00000391980.7 | c.1028A>T | p.Glu343Val | missense_variant | 4/4 | 1 | NM_182501.4 | ENSP00000375840.2 |
Frequencies
GnomAD3 genomes AF: 0.000134 AC: 20AN: 149246Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000521 AC: 13AN: 249628Hom.: 0 AF XY: 0.0000740 AC XY: 10AN XY: 135178
GnomAD4 exome AF: 0.000169 AC: 247AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.000164 AC XY: 119AN XY: 727226
GnomAD4 genome AF: 0.000134 AC: 20AN: 149246Hom.: 0 Cov.: 32 AF XY: 0.000137 AC XY: 10AN XY: 72938
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 07, 2024 | The c.1028A>T (p.E343V) alteration is located in exon 4 (coding exon 4) of the MTERF4 gene. This alteration results from a A to T substitution at nucleotide position 1028, causing the glutamic acid (E) at amino acid position 343 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at